X-102715009-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001004051.4(GPRASP2):c.140G>C(p.Gly47Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000117 in 1,211,410 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 30 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004051.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000592 AC: 67AN: 113097Hom.: 0 Cov.: 24 AF XY: 0.000454 AC XY: 16AN XY: 35245
GnomAD3 exomes AF: 0.000142 AC: 26AN: 183473Hom.: 0 AF XY: 0.000118 AC XY: 8AN XY: 67915
GnomAD4 exome AF: 0.0000683 AC: 75AN: 1098259Hom.: 0 Cov.: 31 AF XY: 0.0000385 AC XY: 14AN XY: 363617
GnomAD4 genome AF: 0.000592 AC: 67AN: 113151Hom.: 0 Cov.: 24 AF XY: 0.000453 AC XY: 16AN XY: 35309
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.140G>C (p.G47A) alteration is located in exon 5 (coding exon 1) of the GPRASP2 gene. This alteration results from a G to C substitution at nucleotide position 140, causing the glycine (G) at amino acid position 47 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
GPRASP2-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at